MannKind (NASDAQ:MNKD) said the U.S. Food and Drug Administration has approved Afrezza for pediatric patients with diabetes ...
THOUSANDS of Jamaican farmers are being placed on firmer footing through a $50-million protection injection aimed at strengthening the agriculture sector’s ability to withstand extreme weather shocks ...
Median overall survival, a secondary endpoint, reached nearly 3.5 years with Johnson & Johnson's RYBREVANT® plus LAZCLUZE® in atypical EGFR-mutated disease Consistent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results